- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (59)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4814)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2024 (publication date) through Sep 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gosnell JM, Golovko G, Arroyave E, Moghe A, Kueht ML, Saldarriaga OA, McKinney KH, Stevenson HL, Ferguson MR. Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study. World J Diabetes 2024; 15(5): 886-897 [PMID: 38766421 DOI: 10.4239/wjd.v15.i5.886] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i5/886.htm |
| Number | Citing Articles |
| 1 |
Lucy C. Taylor, Gertrude Arthur, Marcella de Carvalho Cruz, David E. Stec, Olufunto O. Badmus. Contribution of Sex Differences to Development of Cardiovascular Disease in Metabolic-Associated Steatotic Liver Disease (MASLD). International Journal of Translational Medicine 2024; 4(4): 782 doi: 10.3390/ijtm4040052
|
| 2 |
Ruey-Shyang Soong, Wan-Ming Chen, An-Tzu Jao, Ming-Che Lee, Szu-Yuan Wu, Chih-Lang Lin. SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes. Diabetes & Metabolism 2025; 51(6): 101698 doi: 10.1016/j.diabet.2025.101698
|
| 3 |
Ze-Xu Zheng, Shu-Min Huang. Heterogeneous outcomes in metabolic dysfunction–associated steatotic liver disease/steatohepatitis with type 2 diabetes: Rethinking risk and management approaches. World Journal of Clinical Cases 2025; 13(29): 110771 doi: 10.12998/wjcc.v13.i29.110771
|